Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli–driven acute inflammation

While the treatment of inflammatory disorders is generally based on inhibiting factors that drive onset of inflammation, these therapies can compromise healing (NSAIDs) or dampen immunity against infections (biologics). In search of new antiinflammatories, efforts have focused on harnessing endogeno...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCI Insight
Egile Nagusiak: Motwani, Madhur P., Colas, Romain A., George, Marc J., Flint, Julia D., Dalli, Jesmond, Richard-Loendt, Angela, De Maeyer, Roel P.H., Serhan, Charles N., Gilroy, Derek W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5926908/
https://ncbi.nlm.nih.gov/pubmed/29563331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.94463
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak